Tiny Cargo provides a novel drug delivery system based on non-immunogenic bovine milk-derived exosomes for protected oral or IV-based delivery of potent therapeutics. They treat ischemic heart disease, gastrointestinal radiation disease, glioblastoma multiforme, and numerous other pathologies.